- Home
- IMNN vs TNON Comparison
IMNN vs TNON Comparison
Compare IMNN & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- TNON
- Stock Information
- Founded
- IMNN 1982
- TNON 2012
- Country
- IMNN United States
- TNON United States
- Employees
- IMNN N/A
- TNON N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- IMNN Health Care
- TNON Health Care
- Exchange
- IMNN Nasdaq
- TNON Nasdaq
- Market Cap
- IMNN 12.1M
- TNON 11.5M
- IPO Year
- IMNN 1985
- TNON 2022
- Fundamental
- Price
- IMNN $6.53
- TNON $1.49
- Analyst Decision
- IMNN Buy
- TNON Strong Buy
- Analyst Count
- IMNN 2
- TNON 3
- Target Price
- IMNN $182.61
- TNON $11.67
- AVG Volume (30 Days)
- IMNN 244.8K
- TNON 13.7M
- Earning Date
- IMNN 08-05-2025
- TNON 08-13-2025
- Dividend Yield
- IMNN N/A
- TNON N/A
- EPS Growth
- IMNN N/A
- TNON N/A
- EPS
- IMNN N/A
- TNON N/A
- Revenue
- IMNN N/A
- TNON $2,947,000.00
- Revenue This Year
- IMNN N/A
- TNON $39.03
- Revenue Next Year
- IMNN N/A
- TNON $66.24
- P/E Ratio
- IMNN N/A
- TNON N/A
- Revenue Growth
- IMNN N/A
- TNON N/A
- 52 Week Low
- IMNN $4.83
- TNON $0.85
- 52 Week High
- IMNN $41.22
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- IMNN 40.89
- TNON 61.29
- Support Level
- IMNN $6.17
- TNON $1.36
- Resistance Level
- IMNN $7.21
- TNON $1.54
- Average True Range (ATR)
- IMNN 0.51
- TNON 0.14
- MACD
- IMNN 0.14
- TNON -0.00
- Stochastic Oscillator
- IMNN 20.45
- TNON 43.18
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.